CCR2-RA-[R]   Click here for help

GtoPdb Ligand ID: 9431

Synonyms: analog 49 (Dasse et al., 2007) [1]
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: CCR2-RA-[R] is an allosteric antagonist of the CC chemokine receptor 2 (CCR2) [1]. Allosteric modulation by CCR2-RA-[R] prevents formation of the G-protein-binding interface and hence G-protein coupling by blocking the required activation-associated changes in receptor conformation [3]. The chemical structure presented here is that held with the PDB X-ray structure reported in [3].
CCR2-RA-[R] is claimed as chiral example 125 in patent US6936633 [4].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

CCR2-RA-[R] is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 57.61
Molecular weight 351.1
XLogP 5.09
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES Clc1ccc(c(c1)F)N1C(C2CCCCC2)C(=C(C1=O)O)C(=O)C
Isomeric SMILES Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C
InChI InChI=1S/C18H19ClFNO3/c1-10(22)15-16(11-5-3-2-4-6-11)21(18(24)17(15)23)14-8-7-12(19)9-13(14)20/h7-9,11,16,23H,2-6H2,1H3/t16-/m1/s1
InChI Key VQNLJXWZGVRLBA-MRXNPFEDSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
References
1. Dasse OA, Evans JL, Zhai H-X, Zou D, Kintigh JT, Chan F, Hamilton K, Hill E, Eckman JB, Higgins PJ et al.. (2007)
Novel, Acidic CCR2 Receptor Antagonists: Lead Optimization.
Lett Drug Des Discov, 4 (4): 263-271. DOI: 10.2174/157018007784619989
2. O'Connor T, Borsig L, Heikenwalder M. (2015)
CCL2-CCR2 Signaling in Disease Pathogenesis.
Endocr Metab Immune Disord Drug Targets, 15 (2): 105-18. [PMID:25772168]
3. Zheng Y, Qin L, Zacarías NV, de Vries H, Han GW, Gustavsson M, Dabros M, Zhao C, Cherney RJ, Carter P et al.. (2016)
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Nature, 540 (7633): 458-461. [PMID:27926736]
4. Zou D, Dasse O, Evans J, Higgins P, Kintigh J, Kondru R, Schwartz E, Knerr L, Zhai H-X. (2005)
Pyrrolidinone derivatives.
Patent number: US6936633. Assignee: Ucb S.A.. Priority date: 03/10/2001. Publication date: 20/08/2005.